PCN46 PHARMACOECONOMIC EVALUATION OF SUNITINIB MALATE FOR FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO
Abstract
Authors
C Tenorio J Vargas P Rizo-Rios O Flores-Gil J Martnez-Fonseca J Mould-Quevedo G Davila-Loaiza